2014
DOI: 10.1007/s40506-014-0034-0
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Tuberculosis Diagnosis: IGRAs and Molecular Biology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 96 publications
0
3
0
Order By: Relevance
“…Resistance to FLQ is associated with mutations in the quinolone resistance determining region (QRDR) in gyrA, and to a lesser extent in gyrB. The reference molecular method to detect these mutations is sequencing, but different methods based on reverse hybridization [12][13][14], real-time PCR or pyrosequencing [15] have also been developed [16][17][18][19][20]. In a previous work, we In Table 3 are presented the mutations detected in the different loci analyzed.…”
Section: Introductionmentioning
confidence: 99%
“…Resistance to FLQ is associated with mutations in the quinolone resistance determining region (QRDR) in gyrA, and to a lesser extent in gyrB. The reference molecular method to detect these mutations is sequencing, but different methods based on reverse hybridization [12][13][14], real-time PCR or pyrosequencing [15] have also been developed [16][17][18][19][20]. In a previous work, we In Table 3 are presented the mutations detected in the different loci analyzed.…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, several molecular tests are available (18)(19)(20)(21), but more studies are still needed to assess their clinical value. For instance, an evaluation has demonstrated the noninferiority of the GenoType MTBDRplus version 2.0 and Nipro line probe assays in comparison to the WHO-endorsed first version of the GenoType MTBDRplus assay for the rapid detection of multidrug-resistant tuberculosis (MDR-TB) (22).…”
mentioning
confidence: 99%
“…1 Because of the slow growth rate of M. tuberculosis, phenotypic drug susceptibility testing (DST) takes several weeks, and different molecular methods have been developed for rapid detection of mutations associated with drug resistance. 5 The objective of this study was to evaluate a molecular method based on multiplex PCR and hybridization on microbeads for simultaneous spoligotyping and detection of mutations associated with rifampicin (RIF) and isoniazid (INH) resistance, termed Tuberculosis-Spoligo-Rifampicin-Isoniazid Typing (TB-SPRINT, Beamedex SAS, Orsay, France). 6 A total of 67 M. tuberculosis complex strains isolated in Spain were retrospectively selected from the collection in Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain.…”
mentioning
confidence: 99%